Sustained Release Excipients Market Size, Share and Trends Analysis Report, By Type (Inorganic Chemicals, and Organic Chemicals), By Application (Oral, Parenteral, and Topical), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Others), Forecast (2022-2028)

The global sustained release excipients market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The increasing prevalence of chronic and topical diseases across the globe has created demand for sustained release excipients which in turn is driving the global sustained release excipients market.  In addition, the acquired benefits of continuous or controlled drug release among patients is also exacerbated for the sustained release excipients market demand.

In June 2020, Evonik launched the RESOMER Precise platform of custom functional excipients to precisely manage the release profile of the parent drug products. Such developments are expected to help the sustained release excipients market growth during the forecast period.

In addition, sustained-release excipients market providers provide their services through retail channels and it increased opportunities for collaborative research in child development those are driven by the emergence of new laws, increased funding opportunities, and increased relationships between private and public companies.The prevalence of the development of excipients substances used in all types of aids such as solid oral ingredients and the formation of liquid, flexible, dispersed, and multi-functional substances.

Furthermore, continued investment in R&D, the presence of advanced research institutes, and the presence of leading pharmaceutical and biopharmaceutical companies create various new opportunities that will contribute to the growth of the sustained release excipients market. For instance, in January 2019, Croda International acquired the Brenntag Biosector for its vaccine with adjuvants portfolio that would be complementary to Croda’s medical excipients portfolio.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By Distribution Channel

 

• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- GlaxoSmithKline plc, Mylan N.V.,Novartis AG Pfizer, Inc., Sun Pharmaceutical Inc. Ltd., and Salix Pharmaceuticals, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Sustained-release excipients Market Report by Segment

By Type

• Inorganic Chemicals
• Organic Chemicals

By Application

• Oral
• Parenteral
• Topical

By Distribution Channel

• Online Pharmacy
• Retail Pharmacy
• Others

Sustained Release excipients Market Report by Region

North America

• The US
• Canada

Europe

• The UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa